This study shows some limitations. First, it does not take into consideration mitochondria derived cfDNA in accordance to their growing interest in respect to inflammation and transplant areas of research 1,2 . A few works reported that mitochondria cfDNA do not show a nucleosomal pattern in the plasma of cancer patients and pregnant women and did consistently show a size distribution much shorter (30-115 bp range) than nuclear cfDNA 1,3 .
Materials and methods

Plasma isolation and cfDNA extraction
All samples were collected in 4-ml EDTA tubes. The blood was centrifuged at 1200 g at 4°C for 10 min. The supernatants were isolated in sterile 1.5 ml Eppendorf tubes and centrifuged at 16 000 g at 4°C for 10 min. Afterwards, the plasma was either immediately handled for DNA extraction or stored at -20°C. CfDNA was extracted from 1 ml of plasma using the QiaAMP Circulating Nucleic Acids Kit (Qiagen) according to the manufacturer's protocol for Conversant Bio samples, QIAmp DNA Mini Blood kit (Qiagen) according to the ''Blood and body fluid protocol'' and our detailed protocol 7 for ICM samples. DNA extracts were kept at -20°C until used. DNA yield was quantified with a Qubit Fluorometer (Invitrogen).
Preparation of the single-stranded sequencing library
Single-stranded sequencing libraries were prepared according to a protocol adapted from Gansauge et al 8 . Briefly, a double-stranded adapter (SI-13), Adapter2, was prepared by combining 4.5 µl TE (pH 8), 0.5 µl 1M NaCl, 10 µl 500 uM oligo Adapter2.1, and 10 µl 500 uM oligo Adapter2.2, incubating at 95°C for 10 seconds, and ramping to 14°C at a rate of 0.1°C/second. Purified cfDNA fragments were dephosphorylated by combining 2X CircLigase II buffer (Epicentre), 5 mM MnCl2, and 1U FastAP (Thermo Fisher) with 0.5-10 ng cfDNA fragments in 20 µl reaction volume and incubating at 37°C for 30 minutes. Fragments were then denatured by heating to 95°C for 3 minutes and were immediately transferred to an ice bath. The reaction was supplemented with 5 pmol biotin-conjugated adapter oligo CL78, 20% PEG-6000 (w/v), and 200U CircLigase II (Epicentre) for a total volume of 40 µl, and incubated overnight with rotation at 60°C, heated to 95°C for 3 minutes, and placed in an ice bath. For each sample, 20 µl MyOne C1 beads (Life Technologies) were washed twice in bead-binding buffer (BBB) (10 mM Tris-HCl [pH 8], 1M NaCl, 1 mM EDTA [pH 8], 0.05% Tween-20, and 0.5% SDS), and resuspended in 250 µl BBB. Adapter-ligated fragments were bound to the beads by rotating for 60 minutes at room temperature. The beads were collected on a magnetic rack and the supernatant was discarded. The beads were washed once with 500 µl wash buffer A (WBA) (10 mM Tris-HCl [pH 8], 1 mM EDTA [pH 8], 0.05% Tween-20, 100 mM NaCl, 0.5% SDS) and once with 500 µl wash buffer B (WBB) (10 mM Tris-HCl [pH 8], 1 mM EDTA [pH 8], 0.05% Tween-20, 100 mM NaCl). The beads were combined with 1X Isothermal Amplification Buffer (NEB), 2.5 uM oligo CL9, 250 uM (each) dNTPs, and 24U Bst 2.0 DNA Polymerase (NEB) in a reaction volume of 50 µl, incubated with gentle shaking by ramping temperature from 15°C to 37°C at 1°C/minute, and held at 37°C for 10 minutes. After collection on a magnetic rack, the beads were washed once with 200 µl WBA, resuspended in 200 µl of stringency wash buffer (SWB) (0.1X SSC, 0.1% SDS), and incubated at 45°C for 3 minutes. The beads were collected again and washed once with 200 µl WBB. The beads were then combined with 1X CutSmart Buffer (NEB), 0.025% Tween-20, 100 uM (each) dNTPs, and 5U T4 DNA Polymerase (NEB), and incubated with gentle shaking for 30 minutes at room temperature. The beads were washed once with each of WBA, SWB, and WBB as described above. The beads were then mixed with 1X CutSmart Buffer (NEB), 5% PEG-6000, 0.025% Tween-20, 2 uM doublestranded Adapter2, 1 mM ATP, and 10U T4 DNA Ligase (NEB), and incubated with gentle shaking for 2 hours at room temperature. The beads were washed once with each of WBA, SWB, and WBB as described above, and resuspended in 25 µl TET buffer (10 mM Tris-HCl [pH 8], 1 mM EDTA [pH 8], 0.05% Tween-20). Second strands were eluted from the beads by heating to 95°C, collecting them on a magnetic rack, and transferring the supernatant to a new tube. Library amplification was monitored by real-time PCR, requiring an average of 4-6 cycles per library.
Size profile analysis by deep sequencing All libraries were sequenced on HISeq 2000 or NextSeq 500 instruments (Illumina). Barcoded single-end reads (SR) and the individual barcoded paired-end reads (PE) were aligned to the human reference genome (GRCH37, 1000 Genomes phase 2 technical reference, ftp://ftp.1000genomes.ebi.ac.uk/vol1/ftp/technical/reference/phase2_reference_assembly_seq uence/) using the ALN algorithm in BWA v0.7.10. PE reads were further processed with BWA SAMPE to resolve ambiguous placement of read pairs or to rescue missing alignments by a more sensitive alignment step around the location of one placed read end. Aligned SR and PE data were stored in BAM format using the samtools API. BAM files for each sample were merged across lanes and sequencing runs. Since SSP-S provides size profile based on detection of ssDNA fragment, length unit was consequently number of nucleotide.
Size profile analysis by Q-PCR
The oligonucleotides primers target DNA sequences of increasing size in human KRAS region intron 2 (SI-14). The size of the amplicons was 60 bp, 73 bp, 101 bp, 145 bp, 185 bp, 249 bp, and 300 bp. The reverse primer used was the same for all sizes. Our Q-PCR experiments followed the MIQE guideline 9 . Q-PCR amplifications were performed at least in duplicate in a 25 µl reaction volume on a CFX96 instrument using the CFX manager software 3.0 (Bio-Rad).
Each PCR reaction mixture was composed of 12.5 µl PCR mix (Bio-Rad Super mix SYBR Green), 2.5 µl of each amplification primer (0.3 pmol/µl, final concentration), 2.5 µl PCR-analyzed water, and 5 µl DNA extract. Thermal cycling consisted of three repeated steps: a 3-min Hotstart Polymerase activation denaturation step at 95°C followed by 40 repeated cycles at 95°C for 10 s and then at 60°C for 30 s. Melting curves were obtained by increasing the temperature from 55°C to 90°C with a plate reading every 0.2°C. As calibrators for quantification, serial dilutions of genomic DNA from the DIFI cell line were used. Sample concentrations were extrapolated from this standard curve. Negative controls were used in duplicate for each experiment. The efficiency of these primers was assessed using as the reference a human genomic DNA purchased from Promega. This DNA was quantified by Q-PCR using the different Analysis of the amplification of short mutant synthetic DNA fragments by Q-PCR In order to confirm that targeting short sequences amplify the expected fragment size and that no bias exists in the preferential amplification of larger fragment, we designed two fragments of mutant synthetic DNA and they were synthetized by Eurofins Genomics GeneStrands. These fragments contain the G12V mutated KRAS exon 2 gene sequence. The fragment lengths are 61 bp and 103 bp, respectively, and they were amplified by Q-PCR using a primers targeting a sequence of 61 bp , and the products were analyzed by agarose gel electrophoresis. The amplicon size was 61 bp corresponding to the mutated DNA sequence. The Q-PCR amplification conditions were the same except that the water in the SYBR mix was replaced by an oligoblocker, which targets the non-mutated DNA sequence. As calibrators for quantification, serial dilutions of genomic DNA from the SW620 cell line were used. A positive control of the mutation from the SW620 cell line was amplified. A negative control of the mutation from the DIFI cell line was amplified. Agarose gel was performed with 2.75% ultrapure agarose 1000 (Invitrogen). We prepared DNA samples with 6X DNA Loading dye, 1 volume for 5 volume of DNA. For the PCR products, we loaded 20 μl of each sample and for the synthetic DNA fragments 30 μl (54 ng of DNA). For both analytical approaches HF fraction is statistically different to the MF + WF fraction when using either Q-PCR or SSP-S (p= 2,7.10-21, and p=7.35.10-9, respectively). 
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